https://jnk-in-8inhibitor.com/....revised-cerebral-lit
So far, there is apparently no evidence of increased toxicity correlated to the higher posaconazole publicity attained using the regime of these formulations. The larger systemic availability of posaconazole for the delayed-release tablet and intravenous formulation have resulted in these two formulations being preferable both for prophylaxis and remedy for invasive fungal infection. This analysis aimed to integrate current understanding on posaconazole pharmacokinetics, pharmac
Like
Comment
Share
